Role of nitric oxide in the anticonvulsive effect of progesterone

Epilepsy and Behavior

Volumn 13, Issue 4, 2008, Pages 579-584

  Gholipour, Taha ^a,b   Jabbarzadeh, Atieh ^a,c   Riazi, Kiarash ^a   Rasouli, Aylar ^a,c   Nezami, Behtash Ghazi ^a   Sharifzadeh, Mohammad ^b   Dehpour, Ahmad Reza ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clonic seizure threshold; Estrous cycle; Mice; Nitric oxide; Pentylenetetrazole; Progesterone

Indexed keywords

ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; FEMALE; MOUSE; MYOCLONUS SEIZURE; NONHUMAN; OVARIECTOMY; SIGNAL TRANSDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; ARGININE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OVARIECTOMY; PENTYLENETETRAZOLE; PROGESTERONE; SEIZURES; TIME FACTORS;

EID: 54049087307     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2008.07.011     Document Type: Article

References (91)

1. Herzog A.G., Klein P., and Ransil B.J. Three patterns of catamenial epilepsy. Epilepsia 38 (1997) 1082-1088
2. Rosciszewska D. Analysis of seizure dispersion during menstrual cycle in women with epilepsy. Monogr Neural Sci 5 (1980) 280-284
3. Bauer J., Burr W., and Elger C.E. Seizure occurrence during ovulatory and anovulatory cycles in patients with temporal lobe epilepsy: a prospective study. Eur J Neurol 5 (1998) 83-88
4. Foldvary-Schaefer N., and Falcone T. Catamenial epilepsy: pathophysiology, diagnosis, and management. Neurology 61 (2003) S2-S15
5. Herzog A.G. Catamenial epilepsy: definition, prevalence, pathophysiology and treatment. Seizure 17 (2008) 151-159
6. Rogawski M.A. Progesterone, neurosteroids, and the hormonal basis of catamenial epilepsy. Ann Neurol 53 (2003) 288-291
7. Scharfman H.E., and MacLusky N.J. The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female. Epilepsia 47 (2006) 1423-1440
8. Levine J.E., Chappell P.E., Schneider J.S., Sleiter N.C., and Szabo M. Progesterone receptors as neuroendocrine integrators. Front Neuroendocrinol 22 (2001) 69-106
9. Mani S.K., Blaustein J.D., and O'Malley B.W. Progesterone receptor function from a behavioral perspective. Horm Behav 31 (1997) 244-255
10. Parsons B., Rainbow T.C., MacLusky N.J., and McEwen B.S. Progestin receptor levels in rat hypothalamic and limbic nuclei. J Neurosci 2 (1982) 1446-1452
11. Sadri-Vakili G., Johnson D.W., Janis G.C., Gibbs T.T., Pierce R.C., and Farb D.H. Inhibition of NMDA-induced striatal dopamine release and behavioral activation by the neuroactive steroid 3α-hydroxy-5β-pregnan-20-one hemisuccinate. J Neurochem 86 (2003) 92-101
12. Rupprecht R. The neuropsychopharmacological potential of neuroactive steroids. J Psychiatr Res 31 (1997) 297-314
13. Rupprecht R., Koch M., Montkowski A., et al. Assessment of neuroleptic-like properties of progesterone. Psychopharmacology (Berl) 143 (1999) 29-38
14. Kaminski R.M., Livingood M.R., and Rogawski M.A. Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice. Epilepsia 45 (2004) 864-867
15. Malayev A., Gibbs T.T., and Farb D.H. Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids. Br J Pharmacol 135 (2002) 901-909
16. Kokate T.G., Svensson B.E., and Rogawski M.A. Anticonvulsant activity of neurosteroids: correlation with γ-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther 270 (1994) 1223-1229
17. Pluchino N., Luisi M., Lenzi E., et al. Progesterone and progestins: effects on brain, allopregnanolone and β-endorphin. J Steroid Biochem Mol Biol 102 (2006) 205-213
18. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 (1986) 1004-1007
19. Kokate T.G., Banks M.K., Magee T., Yamaguchi S., and Rogawski M.A. Finasteride, a 5α-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. J Pharmacol Exp Ther 288 (1999) 679-684
20. Lonsdale D., and Burnham W.M. The anticonvulsant effects of allopregnanolone against amygdala-kindled seizures in female rats. Neurosci Lett 411 (2007) 147-151
21. Garthwaite J., Charles S.L., and Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336 (1988) 385-388
22. Nidhi G., Balakrishnan S., and Pandhi P. Role of nitric oxide in electroshock and pentylenetetrazole seizure threshold in rats. Methods Find Exp Clin Pharmacol 21 (1999) 609-612
23. Theard M.A., Baughman V.L., Wang Q., Pelligrino D.A., and Albrecht R.F. The role of nitric oxide in modulating brain activity and blood flow during seizure. NeuroReport 6 (1995) 921-924
24. Riazi K., Roshanpour M., Rafiei-Tabatabaei N., Homayoun H., Ebrahimi F., and Dehpour A.R. The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway. Br J Pharmacol 147 (2006) 935-943
25. Nicoletti F., Speciale C., Sortino M.A., et al. Comparative effects of estradiol benzoate, the antiestrogen clomiphene citrate, and the progestin medroxyprogesterone acetate on kainic acid-induced seizures in male and female rats. Epilepsia 26 (1985) 252-257
26. Morrell M.J. Epilepsy in women: the science of why it is special. Neurology 53 (1999) S42-S48
27. Backstrom T. Epilepsy in women: oestrogen and progesterone plasma levels. Experientia 32 (1976) 248-249
28. Sadeghipour H.R., Ghasemi M., Sadeghipour H., et al. Nitric oxide involvement in estrous cycle-dependent changes of the behavioral responses of female rats in the elevated plus-maze test. Behav Brain Res 178 (2007) 10-17
29. Gonzalez-Flores O., and Etgen A.M. The nitric oxide pathway participates in estrous behavior induced by progesterone and some of its ring A-reduced metabolites. Horm Behav 45 (2004) 50-57
30. Chu H.P., Morales J.C., and Etgen A.M. Cyclic GMP may potentiate lordosis behaviour by progesterone receptor activation. J Neuroendocrinol 11 (1999) 107-113
31. Gonzalez-Flores O., Shu J., Camacho-Arroyo I., and Etgen A.M. Regulation of lordosis by cyclic 3′, 5′-guanosine monophosphate, progesterone, and its 5α-reduced metabolites involves mitogen-activated protein kinase. Endocrinology 145 (2004) 5560-5567
32. Mani S.K., Allen J.M., Rettori V., McCann S.M., O'Malley B.W., and Clark J.H. Nitric oxide mediates sexual behavior in female rats. Proc Natl Acad Sci USA 91 (1994) 6468-6472
33. Mandhane S.N., Aavula K., and Rajamannar T. Timed pentylenetetrazol infusion test: a comparative analysis with s.c. PTZ and MES models of anticonvulsant screening in mice. Seizure 16 (2007) 636-644
34. Loscher W., Honack D., Fassbender C.P., and Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs: III. Pentylenetetrazole seizure models. Epilepsy Res 8 (1991) 171-189
35. Galeeva A.Y., Tuohimaa P., and Shalyapina V.G. The role of sex steroids in forming anxiety states in female mice. Neurosci Behav Physiol 33 (2003) 415-420
36. Mora S., Dussaubat N., and Diaz-Veliz G. Effects of the estrous cycle and ovarian hormones on behavioral indices of anxiety in female rats. Psychoneuroendocrinology 21 (1996) 609-620
37. Galeeva A.Y., Pivina S.G., Tuohimaa P., and Ordyan N.E. Involvement of nuclear progesterone receptors in the formation of anxiety in female mice. Neurosci Behav Physiol 37 (2007) 843-848
38. Reddy D.S. Role of neurosteroids in catamenial epilepsy. Epilepsy Res 62 (2004) 99-118
39. French J.A. Catamenial epilepsy: the elusive condition. Epilepsy Curr 5 (2005) 113-114
40. Duncan S., Read C.L., and Brodie M.J. How common is catamenial epilepsy?. Epilepsia 34 (1993) 827-831
41. Finn D.A., and Gee K.W. The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid. J Pharmacol Exp Ther 271 (1994) 164-170
42. Wilson M.A. Influences of gender, gonadectomy, and estrous cycle on GABA/BZ receptors and benzodiazepine responses in rats. Brain Res Bull 29 (1992) 165-172
43. Riazi K., Honar H., Homayoun H., et al. Sex and estrus cycle differences in the modulatory effects of morphine on seizure susceptibility in mice. Epilepsia 45 (2004) 1035-1042
44. Maguire J.L., Stell B.M., Rafizadeh M., and Mody I. Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci 8 (2005) 797-804
45. Kokate T.G., Cohen A.L., Karp E., and Rogawski M.A. Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice. Neuropharmacology 35 (1996) 1049-1056
46. Czlonkowska A.I., Krzascik P., Sienkiewicz-Jarosz H., et al. The effects of neurosteroids on picrotoxin-, bicuculline- and NMDA-induced seizures, and a hypnotic effect of ethanol. Pharmacol Biochem Behav 67 (2000) 345-353
47. Weiland N.G. Estradiol selectively regulates agonist binding sites on the N-methyl-d-aspartate receptor complex in the CA1 region of the hippocampus. Endocrinology 131 (1992) 662-668
48. Phillis J.W. Potentiation of the depression by adenosine of rat cerebral cortical neurones by progestational agents. Br J Pharmacol 89 (1986) 693-702
49. Murphy D.D., Cole N.B., Greenberger V., and Segal M. Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J Neurosci 18 (1998) 2550-2559
50. Ikeda T., Matsuki N., and Yamada M.K. Estrogen produced in cultured hippocampal neurons is a functional regulator of a GABAergic machinery. Br J Neurosci Res 84 (2006) 1771-1777
51. Wallis C.J., and Luttge W.G. Influence of estrogen and progesterone on glutamic acid decarboxylase activity in discrete regions of rat brain. J Neurochem 34 (1980) 609-613
52. Wong M., and Moss R.L. Patch-clamp analysis of direct steroidal modulation of glutamate receptor-channels. J Neuroendocrinol 6 (1994) 347-355
53. Woolley C.S., Weiland N.G., McEwen B.S., and Schwartzkroin P.A. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J Neurosci 17 (1997) 1848-1859
54. Mohammad S., Abolhassan A., and Pourgholami M.H. Evaluation of the anticonvulsant profile of progesterone in male amygdala-kindled rats. Epilepsy Res 30 (1998) 195-202
55. Frye C.A., and Scalise T.J. Anti-seizure effects of progesterone and 3α, 5α-THP in kainic acid and perforant pathway models of epilepsy. Psychoneuroendocrinology 25 (2000) 407-420
56. Lonsdale D. Effect of thiamine tetrahydrofurfuryl disulfide on audiogenic seizures in DBA/2J mice. Dev Pharmacol Ther 4 (1982) 28-36
57. Foldvary-Schaefer N., Harden C., Herzog A., and Falcone T. Hormones and seizures. Cleve Clin J Med 71 Suppl. 2 (2004) S11-S18
58. Lonsdale D., Nylen K., and McIntyre Burnham W. The anticonvulsant effects of progesterone and its metabolites on amygdala-kindled seizures in male rats. Brain Res 1101 (2006) 110-116
59. Reddy D.S., Castaneda D.C., O'Malley B.W., and Rogawski M.A. Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice. J Pharmacol Exp Ther 310 (2004) 230-239
60. Edwards H.E., Epps T., Carlen P.L., and MacLusky N.J. Progestin receptors mediate progesterone suppression of epileptiform activity in tetanized hippocampal slices in vitro. Neuroscience 101 (2000) 895-906
61. Rupprecht R., Reul J.M., Trapp T., et al. Progesterone receptor-mediated effects of neuroactive steroids. Neuron 11 (1993) 523-530
62. Beyer C., Gonzalez-Flores O., and Gonzalez-Mariscal G. Ring A reduced progestins potently stimulate estrous behavior in rats: paradoxical effect through the progesterone receptor. Physiol Behav 58 (1995) 985-993
63. Cheney D.L., Uzunov D., Costa E., and Guidotti A. Gas chromatographic-mass fragmentographic quantitation of 3 α-hydroxy-5 α-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats. J Neurosci 15 (1995) 4641-4650
64. Rupprecht R., and Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 22 (1999) 410-416
65. Mani S.K. Signaling mechanisms in progesterone-neurotransmitter interactions. Neuroscience 138 (2006) 773-781
66. Homayoun H., Khavandgar S., Namiranian K., Gaskari S.A., and Dehpour A.R. The role of nitric oxide in anticonvulsant and proconvulsant effects of morphine in mice. Epilepsy Res 48 (2002) 33-41
67. Starr M.S., and Starr B.S. Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor l-NAME. Pharmacol Biochem Behav 45 (1993) 321-325
68. Tsuda M., Suzuki T., and Misawa M. Aggravation of DMCM-induced seizure by nitric oxide synthase inhibitors in mice. Life Sci 60 (1997) PL339-PL343
69. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 (1991) 109-142
70. Buisson A., Lakhmeche N., Verrecchia C., Plotkine M., and Boulu R.G. Nitric oxide: an endogenous anticonvulsant substance. NeuroReport 4 (1993) 444-446
71. Osonoe K., Mori N., Suzuki K., and Osonoe M. Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats. Brain Res 663 (1994) 338-340
72. Mulsch A., Busse R., Mordvintcev P.I., et al. Nitric oxide promotes seizure activity in kainate-treated rats. NeuroReport 5 (1994) 2325-2328
73. Frye C.A., and Rhodes M.E. Infusions of 5α-pregnan-3α-ol-20-one (3α,5α-THP) to the ventral tegmental area, but not the substantia nigra, enhance exploratory, anti-anxiety, social and sexual behaviours and concomitantly increase 3α,5α-THP concentrations in the hippocampus, diencephalon and cortex of ovariectomised oestrogen-primed rats. J Neuroendocrinol 18 (2006) 960-975
74. Hobbs W.R., Rall T.W., and Verdoon T.A. Hypnotics and sedatives. In: Hardman J.G., Goodman Gilman A., Limbird L., and Rall T.W. (Eds). Goodman & Gilman's the pharmacological basis of therapeutics (1996), McGraw-Hill, New York 361-366
75. Paul V. The effect of N-nitro-l-arginine methyl ester posttreatment on the anticonvulsant effect of phenobarbitone and diazepam on picrotoxin-induced convulsions in rats. Pharmacol Biochem Behav 74 (2003) 789-794
76. Paul V., and Subramanian E.H. Evidence for an involvement of nitric oxide and γ aminobutyric acid in the anticonvulsant action of l-arginine on picrotoxin-induced convulsions in rats. Pharmacol Biochem Behav 72 (2002) 515-519
77. BG Zarri.I., Cupello A., Rapallino M.V., and Robello M. Modulation by nitric oxide of rat brain GABA-A receptors. Neurosci Lett 180 (1994) 239-242
78. Beyenburg S., Stoffel-Wagner B., Bauer J., et al. Neuroactive steroids and seizure susceptibility. Epilepsy Res 44 (2001) 141-153
79. Chapman A.G. Glutamate and epilepsy. J Nutr 130 (2000) 1043S-1045S
80. Mungrue I.N., and Bredt D.S. nNOS at a glance: implications for brain and brawn. J Cell Sci 117 (2004) 2627-2629
81. Montague P.R., Gancayco C.D., Winn M.J., Marchase R.B., and Friedlander M.J. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 263 (1994) 973-977
82. Manzoni O., Prezeau L., Desagher S., et al. Sodium nitroprusside blocks NMDA receptors via formation of ferrocyanide ions. NeuroReport 3 (1992) 77-80
83. Aizenman E., and Potthoff W.K. Lack of interaction between nitric oxide and the redox modulatory site of the NMDA receptor. Br J Pharmacol 126 (1999) 296-300
84. Homayoun H., Khavandgar S., and Dehpour A.R. The involvement of endogenous opioids and nitricoxidergic pathway in the anticonvulsant effects of foot-shock stress in mice. Epilepsy Res 49 (2002) 131-142
85. Frenk H. Pro- and anticonvulsant actions of morphine and the endogenous opioids: involvement and interactions of multiple opiate and non-opiate systems. Brain Res 287 (1983) 197-210
86. Krzanowska E.K., and Bodnar R.J. Morphine antinociception elicited from the ventrolateral periaqueductal gray is sensitive to sex and gonadectomy differences in rats. Brain Res 821 (1999) 224-230
87. Stoffel E.C., Ulibarri C.M., Folk J.E., Rice K.C., and Craft R.M. Gonadal hormone modulation of μ, κ, and δ opioid antinociception in male and female rats. J Pain 6 (2005) 261-274
88. Stoffel E.C., Ulibarri C.M., and Craft R.M. Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats. Pain 103 (2003) 285-302
89. Mogil J.S., Chesler E.J., Wilson S.G., Juraska J.M., and Sternberg W.F. Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype. Neurosci Biobehav Rev 24 (2000) 375-389
90. Gupta D.S., von Gizycki H., and Gintzler A.R. Sex-/ovarian steroid-dependent release of endomorphin 2 from spinal cord. J Pharmacol Exp Ther 321 (2007) 635-641
91. Cernadas M.R., Lopez-Farre A., Riesco A., et al. Renal and systemic effects of amino acids administered separately: comparison between l-arginine and non-nitric oxide donor amino acids. J Pharmacol Exp Ther 263 (1992) 1023-1029